Amit Bahl is Consultant Clinical Oncologist and Clinical Director at Bristol Haematology & Oncology Centre with a special interest in breast and urological cancers. He has led and developed the prostate brachytherapy service at Bristol. He has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer at oncology departments elsewhere in the country. Prior to his current roles, Dr Bahl became Member of the Royal College of Physicians (UK) and trained in Clinical Oncology, achieving the Fellowship of the Royal College of Radiologists qualiﬁcation. He is a current member of the National Cancer Research Institute Clinical Studies Groups for prostate and bladder cancer, college tutor of the Royal College of Radiologists and has supervised several MD theses in breast and prostate cancer research. He has previously been in the NCRI Renal clinical studies group. He is an Executive Committee member of the British Uro-oncology group. Dr Bahl is actively involved in research into breast, prostate and bladder cancers, participates in clinical trials locally and nationally and regularly publishes articles in these research areas and has several presentations at national and international meetings.
In 2012, Dr Bahl has been awarded the Cochrane Shanks Jalil travelling Professorship by the Royal College of Radiologists, London.